Further studies that evaluated markers as continuous variables demonstrated that the expression intensities of antigens CD13, CD56, CD64, CD117, and myeloperoxidase are significantly different between APL and non-APL AML. This evidence concerns the gene KIT and acute myeloid leukemia.